Cataldo Doria, MD, PhD
Thomas Jefferson University and Hospital
1
1
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Debra Barton, RN, PhD, AOCN, FAAN
Mayo Clinic
Shared therapeutic areas:
Ravi D. Rao, MD, MBBS
Mayo Clinic
Shared therapeutic areas:
Jeffrey J. Raizer, MD
Robert H. Lurie Cancer Center
Shared therapeutic areas:
Christina A. Meyers, PhD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Judith Paice, PhD, RN
Northwestern University
Shared therapeutic areas:
Christine Chevreau-Dalbianco, MD
Institut Claudius Regaud
Shared therapeutic areas:
Brigitte C. Widemann, MD
National Cancer Institute (NCI)
Shared therapeutic areas:
Scott Bradfield, MD
Nemours Children's Clinic
Shared therapeutic areas:
Patrick J. Creaven, MBBS, PhD
Roswell Park Cancer Institute
Shared therapeutic areas:
Roderick Johnson, MD
Leeds General Infirmary
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Switching From One Type of Anti-rejection Drug (Tacrolimus or Cyclosporine) to Another (Sirolimus) Approximately 90-180 Days After Liver Transplantation
All 1 trials loaded